Brief: BBS-Bioactive Bone Substitutes Says Periodic Audit of Co's Pharmaceutical Factory Permit Successful

BBS-Bioactive Bone Substitutes Oyj

17/05/2023 17:03

May 17 (Reuters) - BBS-Bioactive Bone Substitutes Oyj
 BONEH.HE :
    * FIMEA HAS CONDUCTED A REGULAR PERIODIC AUDIT REGARDING
COMPANY'S
PHARMACEUTICAL FACTORY PERMIT
    * BASED ON FEEDBACK GIVEN, AUDIT WAS SUCCESSFUL WITH NO
SIGNIFICANT DEFICIENCIES FOUND
    * THIS AUDIT WAS NOT DIRECTLY CONNECTED TO ONGOING CE
MARKING
PROCESS

Source text for Eikon:  urn:newsml:reuters.com:*:nGNEbzfBXB
Further company coverage:  BONEH.HE 

 ((Reuters.Briefs@thomsonreuters.com;))